Company intelligence / Profile preview

Baekeland Fund II

Ghent, Belgium

Ownership: Private
Development stage: Other

Overview

Baekeland Fund II was a venture capital fund established in 2005 to invest €11.1 million in seed and early-stage high-tech and life sciences spin-off companies originating from Ghent University research labs in Belgium. It is no longer active, likely having wound down as a fixed-term fund after 2013.

Industry: Investors

Partnerships

Ghent University TechTransferKBC Private EquityFortis Private Equity Belgium

Beyond the preview

Go deeper on Baekeland Fund II.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baekeland Fund II.

Explore the full profile